Blue Door Asset Management LLC Sells 463,535 Shares of Avantor, Inc. $AVTR

Blue Door Asset Management LLC decreased its holdings in Avantor, Inc. (NYSE:AVTR) by 54.7% during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 383,700 shares of the company’s stock after selling 463,535 shares during the quarter. Avantor accounts for approximately 2.7% of Blue Door Asset Management LLC’s investment portfolio, making the stock its 12th biggest holding. Blue Door Asset Management LLC’s holdings in Avantor were worth $5,165,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in the stock. Dodge & Cox raised its stake in shares of Avantor by 17.1% in the second quarter. Dodge & Cox now owns 117,433,484 shares of the company’s stock worth $1,580,655,000 after purchasing an additional 17,170,761 shares during the last quarter. 1832 Asset Management L.P. boosted its position in shares of Avantor by 89.8% during the first quarter. 1832 Asset Management L.P. now owns 18,127,204 shares of the company’s stock valued at $293,842,000 after buying an additional 8,578,493 shares during the last quarter. Norges Bank bought a new stake in Avantor during the second quarter worth $108,167,000. The Manufacturers Life Insurance Company raised its position in Avantor by 53.2% in the 1st quarter. The Manufacturers Life Insurance Company now owns 14,034,699 shares of the company’s stock valued at $227,502,000 after buying an additional 4,876,524 shares during the last quarter. Finally, Clarkston Capital Partners LLC raised its position in Avantor by 45.8% in the 2nd quarter. Clarkston Capital Partners LLC now owns 13,982,090 shares of the company’s stock valued at $188,199,000 after buying an additional 4,390,140 shares during the last quarter. Institutional investors and hedge funds own 95.08% of the company’s stock.

Avantor Price Performance

Shares of NYSE AVTR opened at $11.55 on Thursday. The company has a current ratio of 1.49, a quick ratio of 0.96 and a debt-to-equity ratio of 0.65. The stock has a fifty day simple moving average of $12.56 and a two-hundred day simple moving average of $12.87. Avantor, Inc. has a 1-year low of $10.62 and a 1-year high of $23.32. The firm has a market cap of $7.87 billion, a price-to-earnings ratio of -88.81, a price-to-earnings-growth ratio of 3.66 and a beta of 0.93.

Avantor (NYSE:AVTR) last issued its earnings results on Wednesday, October 29th. The company reported $0.22 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.23 by ($0.01). The firm had revenue of $1.62 billion during the quarter, compared to the consensus estimate of $1.65 billion. Avantor had a negative net margin of 1.25% and a positive return on equity of 10.91%. The business’s quarterly revenue was down 5.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.26 earnings per share. Avantor has set its FY 2025 guidance at 0.880-0.920 EPS. Analysts anticipate that Avantor, Inc. will post 1.06 earnings per share for the current year.

Insider Activity

In other news, Director Sanjeev K. Mehra purchased 350,000 shares of the stock in a transaction dated Friday, December 5th. The shares were purchased at an average cost of $11.09 per share, with a total value of $3,881,500.00. Following the completion of the acquisition, the director owned 350,000 shares in the company, valued at $3,881,500. This represents a ∞ increase in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Gregory L. Summe acquired 100,000 shares of the business’s stock in a transaction dated Thursday, October 30th. The stock was purchased at an average price of $11.25 per share, with a total value of $1,125,000.00. Following the completion of the transaction, the director directly owned 300,000 shares of the company’s stock, valued at $3,375,000. This trade represents a 50.00% increase in their position. The SEC filing for this purchase provides additional information. Corporate insiders own 1.20% of the company’s stock.

Analyst Ratings Changes

Several analysts have recently issued reports on AVTR shares. Barclays reiterated an “equal weight” rating and issued a $12.00 target price (down previously from $15.00) on shares of Avantor in a research note on Thursday, October 30th. Raymond James Financial downgraded shares of Avantor from an “outperform” rating to a “market perform” rating in a research report on Tuesday, November 4th. UBS Group set a $12.00 target price on shares of Avantor in a research report on Thursday, October 30th. Evercore ISI cut their target price on Avantor from $16.00 to $14.00 and set an “outperform” rating on the stock in a research note on Thursday, October 30th. Finally, JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a $12.00 target price (down from $14.00) on shares of Avantor in a report on Thursday, October 30th. Four analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $14.42.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.